State-of-the-Art Clinical Trial Feasibility: Finding the Right Sites and Populations for Your Clinical Trials

Learn how to find the right sites and populations for your clinical trials.

Recruitment failures pose significant risks to clinical development programs globally, driving up costs and delaying patient access to needed health products. Recent evidence implicates inaccurate trial feasibility as a significant underlying factor in clinical trial recruitment failure. Therefore, a thorough approach to clinical trial feasibility is a critical success factor.

In this webinar, we will highlight pitfalls associated with current approaches to pre-trial feasibility assessment and showcase the industry-leading SGS Health Science approach to data-driven feasibility.

Speaker

Olawale Salami
Health Science - Head Project Management and Feasibility

Dr. Olawale Salami is physician, and his post-doctoral research at the University of Lausanne, Switzerland focused on the impact of lung microbiota on respiratory infections and drug development in chronic lung diseases. Over the last 10 years, Dr. Salami has worked on phase 1 to phase 4 studies on a variety of therapeutic areas in adults and children.

Arash Ghalamkarpour, MD, PhD
Health Science - Associate Medical Director

Dr. Arash Ghalamkarpour is an MD and holds a PhD in Biomedical Sciences. He has held the role of Associate Medical Director at SGS since 2016. His main responsibilities include supporting clinical development programs and strategic feasibility assessments in patient studies.

For further information, please contact:

Clinical Research
t: +32 15 27 32 45